Dampening abnormal fight or flight reflex may delay HD onset and reduces symptom worsening

Results from a randomized, phase 2 clinical trial show that adding high-dose, intravenous vitamin C to chemotherapy doubles the overall survival of patients with late-stage metastatic pancreatic cancer. The findings mark another success for a therapy which has overcome many hurdles in the almost 20 years UI researchers have persevered to demonstrate its benefit for cancer patients.

The genetic mutation that causes Huntington’s disease, a devastating brain disease that disrupts mobility and diminishes cognitive ability, may also enhance early brain development and play a role in promoting human intelligence. “The finding suggests that early in life, the gene mutation is actually beneficial to brain development, but that early benefit later becomes a liability,” says Peg Nopoulos, MD, professor and head of psychiatry at the UI Carver College of Medicine.